STEPHEN H. RUSCKOWSKI - 28 Jul 2021 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
Chairman, CEO and President, Director
Signature
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski
Issuer symbol
DGX
Transactions as of
28 Jul 2021
Net transactions value
-$20,922,096
Form type
4
Filing time
30 Jul 2021, 16:16:08 UTC
Previous filing
28 Jul 2021
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Options Exercise $13,387,447 +139,751 +49% $95.80 424,178 28 Jul 2021 Direct F1
transaction DGX Common Stock Sale $19,584,845 -139,751 -33% $140.14 284,427 28 Jul 2021 Direct F1, F2
transaction DGX Common Stock Options Exercise $507,714 +5,300 +1.9% $95.80 289,727 29 Jul 2021 Direct F1
transaction DGX Common Stock Sale $745,132 -5,300 -1.8% $140.59 284,427 29 Jul 2021 Direct F1, F3
transaction DGX Common Stock Options Exercise $401,668 +4,193 +1.5% $95.80 288,620 29 Jul 2021 Direct F1
transaction DGX Common Stock Sale $592,119 -4,193 -1.5% $141.22 284,427 29 Jul 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise $13,387,447 -139,751 -94% $95.80 9,493 28 Jul 2021 Common Stock 139,751 $95.80 Direct F1, F5
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise $507,714 -5,300 -56% $95.80 4,193 29 Jul 2021 Common Stock 5,300 $95.80 Direct F1, F5
transaction DGX Non-Qualifed Stock Option (right to buy) Options Exercise $401,668 -4,193 -100% $95.80 0 29 Jul 2021 Common Stock 4,193 $95.80 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $140.00 to $140.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $140.06 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $141.06 to $141.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020.